{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:33Z","timestamp":1791218133174,"version":"4.1.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:00:00Z","timestamp":1334016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease\u2013mineral bone disorder (CKD-MBD) is defined by abnormalities in mineral and hormone metabolism, bone histomorphometric changes, and\/or the presence of soft-tissue calcification. Emerging evidence suggests that features of CKD-MBD may occur early in disease progression and are associated with changes in osteocyte function. To identify early changes in bone, we utilized the jck mouse, a genetic model of polycystic kidney disease that exhibits progressive renal disease. At 6 weeks of age, jck mice have normal renal function and no evidence of bone disease but exhibit continual decline in renal function and death by 20 weeks of age, when approximately 40% to 60% of them have vascular calcification. Temporal changes in serum parameters were identified in jck relative to wild-type mice from 6 through 18 weeks of age and were subsequently shown to largely mirror serum changes commonly associated with clinical CKD-MBD. Bone histomorphometry revealed progressive changes associated with increased osteoclast activity and elevated bone formation relative to wild-type mice. To capture the early molecular and cellular events in the progression of CKD-MBD we examined cell-specific pathways associated with bone remodeling at the protein and\/or gene expression level. Importantly, a steady increase in the number of cells expressing phosphor-Ser33\/37-\u03b2-catenin was observed both in mouse and human bones. Overall repression of Wnt\/\u03b2-catenin signaling within osteocytes occurred in conjunction with increased expression of Wnt antagonists (SOST and sFRP4) and genes associated with osteoclast activity, including receptor activator of NF-\u03baB ligand (RANKL). The resulting increase in the RANKL\/osteoprotegerin (OPG) ratio correlated with increased osteoclast activity. In late-stage disease, an apparent repression of genes associated with osteoblast function was observed. These data confirm that jck mice develop progressive biochemical changes in CKD-MBD and suggest that repression of the Wnt\/\u03b2-catenin pathway is involved in the pathogenesis of renal osteodystrophy. \u00a9 2012 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.1630","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T10:34:48Z","timestamp":1334054088000},"page":"1757-1772","source":"Crossref","is-referenced-by-count":233,"title":["Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy"],"prefix":"10.1093","volume":"27","author":[{"given":"Yves","family":"Sabbagh","sequence":"first","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Giorgeti","family":"Graciolli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O'Brien","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene Machado","family":"dos Reis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ryan","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Phillips","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Boulanger","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Song","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bracken","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ledbetter","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dechow","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M Health Science Center, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia F","family":"Canziani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluizio B","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa MA","family":"Moyses","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C","family":"Schiavi","sequence":"additional","affiliation":[{"name":"The Sanofi-Genzyme R&D Center, Genzyme, A Sanofi Company, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,10]]},"reference":[{"key":"2024020318275147300_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA."},{"key":"2024020318275147300_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","article-title":"The burden of kidney disease: improving global outcomes","volume":"66","author":"Eknoyan","year":"2004","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med."},{"key":"2024020318275147300_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2215\/CJN.06240909","article-title":"Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up","volume":"5","author":"Watanabe","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"2024020318275147300_bib5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib6","first-page":"1","volume-title":"The spectrum of mineral and bone disorders in chronic kidney disease","author":"Moe","year":"2010"},{"issue":"Suppl 1","key":"2024020318275147300_bib7","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"2024020318275147300_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semnephrol.2009.01.008","article-title":"The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature","volume":"29","author":"Hruska","year":"2009","journal-title":"Semin Nephrol."},{"key":"2024020318275147300_bib9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","article-title":"Bone markers predict cardiovascular events in chronic kidney disease","volume":"23","author":"Fahrleitner-Pammer","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.1972.03190360019005","article-title":"Calcification of the aorta and osteoporosis. A roentgenographic study","volume":"219","author":"Boukhris","year":"1972","journal-title":"JAMA."},{"key":"2024020318275147300_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2362.1994.tb02024.x","article-title":"Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?","volume":"24","author":"Banks","year":"1994","journal-title":"Eur J Clin Invest."},{"key":"2024020318275147300_bib13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","article-title":"Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study","volume":"20","author":"Hak","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2024020318275147300_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02390833","article-title":"Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study","volume":"68","author":"Kiel","year":"2001","journal-title":"Calcif Tissue Int."},{"key":"2024020318275147300_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/snep.2002.35965","article-title":"Renal osteodystrophy in chronic renal failure","volume":"22","author":"Ho","year":"2002","journal-title":"Semin Nephrol."},{"key":"2024020318275147300_bib17","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1093\/jn\/131.11.2910","article-title":"The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats","volume":"131","author":"Price","year":"2001","journal-title":"J Nutr."},{"key":"2024020318275147300_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","article-title":"Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2024020318275147300_bib19","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2024020318275147300_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2008.646","article-title":"Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure","volume":"75","author":"Lomashvili","year":"2009","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1523-1755.2002.00258.x","article-title":"Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7","volume":"61","author":"Gonzalez","year":"2002","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1053\/j.ajkd.2008.06.024","article-title":"Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study","volume":"52","author":"Barreto","year":"2008","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1601-6343.2005.00345.x","article-title":"Inducers and inhibitors of biomineralization: lessons from pathological calcification","volume":"8","author":"Giachelli","year":"2005","journal-title":"Orthod Craniofac Res."},{"key":"2024020318275147300_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/med.1010","article-title":"Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy","volume":"21","author":"Wallin","year":"2001","journal-title":"Med Res Rev."},{"key":"2024020318275147300_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib27","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"2024020318275147300_bib28","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1681\/ASN.2006020136","article-title":"Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease","volume":"17","author":"Smith","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5\u2013achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"2024020318275147300_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med."},{"key":"2024020318275147300_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev Cell."},{"key":"2024020318275147300_bib33","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","article-title":"Essential role of beta-catenin in postnatal bone acquisition","volume":"280","author":"Holmen","year":"2005","journal-title":"J Biol Chem."},{"key":"2024020318275147300_bib34","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol Cell Biol."},{"key":"2024020318275147300_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1359\/jbmr.090735","article-title":"Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment","volume":"25","author":"Tomiyama","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib37","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1523-1755.2005.00239.x","article-title":"Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors","volume":"67","author":"Barreto","year":"2005","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib38","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2013results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract."},{"key":"2024020318275147300_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00774-007-0788-2","article-title":"Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate[corrected]: an improved method for immunohistochemistry","volume":"26","author":"Gomes","year":"2008","journal-title":"J Bone Miner Metab."},{"key":"2024020318275147300_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.ajkd.2005.01.041","article-title":"Coronary artery calcification in nondialyzed patients with chronic kidney diseases","volume":"45","author":"Mehrotra","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1523-1755.2004.00974.x","article-title":"Determinants of coronary artery calcification in diabetics with and without nephropathy","volume":"66","author":"Mehrotra","year":"2004","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2004.09.022","article-title":"The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination","volume":"45","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib43","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation."},{"key":"2024020318275147300_bib44","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med."},{"key":"2024020318275147300_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res."},{"key":"2024020318275147300_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.ajkd.2004.04.024","article-title":"Kidney disease as a risk factor for recurrent cardiovascular disease and mortality","volume":"44","author":"Weiner","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"2024020318275147300_bib49","volume-title":"The spectrum of mineral and bone disorders in chronic kidney disease","author":"Felsenfeld","year":"2010","edition":"2nd edition"},{"key":"2024020318275147300_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/089686089701700113","article-title":"Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover","volume":"17","author":"Kurz","year":"1997","journal-title":"Perit Dial Int."},{"key":"2024020318275147300_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2003.05.002","article-title":"Misconceptions (3): calcium leaves bone only by resorption and enters only by formation","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone."},{"key":"2024020318275147300_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int."},{"issue":"11","key":"2024020318275147300_bib53","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/jbmr.485","article-title":"The pathophysiology of early stage chronic kidney disease-mineral bone disorder (CKDMBD) and response to phosphate binders in the rat","volume":"26","author":"Moe","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib54","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","author":"Stubbs","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib55","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib57","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","article-title":"Regulation of vascular calcification: roles of phosphate and osteopontin","volume":"96","author":"Giachelli","year":"2005","journal-title":"Circ Res."},{"key":"2024020318275147300_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2003.12.003","article-title":"Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy","volume":"43","author":"Martin","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib59","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"key":"2024020318275147300_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-73-3-516","article-title":"Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients","volume":"73","author":"Solal","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318275147300_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2215\/CJN.01310307","article-title":"Bone and mineral guidelines for patients with chronic kidney disease: a call for revision","volume":"3","author":"Andress","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"2024020318275147300_bib62","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib64","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib65","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib67","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.ki.5002800","article-title":"Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?","volume":"73","author":"Drueke","year":"2008","journal-title":"Kidney Int."},{"key":"2024020318275147300_bib68","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One."},{"key":"2024020318275147300_bib69","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"2024020318275147300_bib70","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jcb.22574","article-title":"Beta-catenin\u2013a supporting role in the skeleton","volume":"110","author":"Case","year":"2010","journal-title":"J Cell Biochem."},{"key":"2024020318275147300_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.ajkd.2006.05.028","article-title":"Variant of adynamic bone disease in hemodialysis patients: fact or fiction?","volume":"48","author":"Rocha","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"2024020318275147300_bib72","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology."},{"key":"2024020318275147300_bib73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone."},{"key":"2024020318275147300_bib74","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS One."},{"key":"2024020318275147300_bib75","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1101\/gad.1702708","article-title":"Parathyroid hormone signaling through low-density lipoprotein-related protein 6","volume":"22","author":"Wan","year":"2008","journal-title":"Genes Dev."},{"key":"2024020318275147300_bib76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020318275147300_bib77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2006090985","article-title":"Nek8 regulates the expression and localization of polycystin-1 and polycystin-2","volume":"19","author":"Sohara","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"2024020318275147300_bib78","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1074\/jbc.M710407200","article-title":"Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II","volume":"283","author":"Xiao","year":"2008","journal-title":"J Biol Chem."},{"key":"2024020318275147300_bib79","doi-asserted-by":"crossref","first-page":"30884","DOI":"10.1074\/jbc.M604772200","article-title":"Cilia-like structures and polycystin-1 in osteoblasts\/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression","volume":"281","author":"Xiao","year":"2006","journal-title":"J Biol Chem."},{"key":"2024020318275147300_bib80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1101\/gad.2008011","article-title":"Strange as it may seem: the many links between Wnt signalling, planar cell polarity, and cilia","volume":"25","author":"Wallingford","year":"2011","journal-title":"Genes Dev."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1630","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/8\/1757\/56560660\/1630_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/8\/1757\/56560660\/1630_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:46:38Z","timestamp":1710326798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/8\/1757-1772\/7598317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,10]]},"references-count":80,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,4,10]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1630","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952758.793458235","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8,1]]},"published":{"date-parts":[[2012,4,10]]}}}